EUVIMEDEUVIMED entdecken
Kohortenstudie

The #Enzian Classification as a Predictor of Hormonal Therapy Response in Endometriosis-Associated Pain: A Retrospective Cohort Study in a Referral Center

Sofia Gambigliani Zoccoli, Antonio La Marca, Martina Di Gianvito, Riccardo Cuoghi Costantini, Matilde Morini, Emma Bertucci, Carlo Alboni

Gynecologic and Obstetric Investigation · 11.03.2026 · 1-7

DOI: 10.1159/000550102 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 11.03.2026. Verfasst von Sofia Gambigliani Zoccoli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mother-Infant Department, University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Endometriosis, Pelvic Pain, Progestins. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study was to evaluate whether ultrasound-based #Enzian classification predicts pain profiles and response to hormonal therapy in patients with endometriosis. Endometriosis is a chronic inflammatory disease affecting 10% of reproductive-age women, often causing debilitating pelvic pain. Although #Enzian is validated for surgical planning, its predictive role in medical therapy remains unexplored.

Design

A retrospective cohort study, including 89 premenopausal patients referred between 2018 and 2023, was conducted. Hormonal therapies included progestin-only pills (dienogest – POP-D or other progestins – POP-O), combined estrogen-progestin pills (dienogest – EP-D or other EP-O), or norethisterone acetate. Pain was assessed via a 0–10 VAS at baseline, ≥3 months, and ≥6 months. Participants/Materials, Setting, Methods: Patients had ultrasound-confirmed endometriosis and were hormone therapy-naïve for ≥6 months. Baseline evaluation included demographic data, reproductive history, prior surgeries, and six pain domains. #Enzian classification mapped lesion location and size (A: rectovaginal/vagina; B: uterosacral/parametria; C: rectum; FA: adenomyosis; FB: bladder; FU: ureter; FI: intestine above rectum; FO: extra pelvic; O: ovary; P: peritoneum; T: fallopian tubes/adhesions). Linear regression and linear mixed-effects models assessed associations between #Enzian compartments and pain trajectories.

Results

Dysmenorrhea occurred in 86.5%, and dyspareunia occurred in 56.2%. Ovarian endometriomas (O) were present in 76.4%, deep infiltrating endometriosis (A, B, C) in 51.7%, and adenomyosis (FA) in 66.3%. POP-D was most effective in reducing ovulatory pain in ovarian (O), uterosacral/parametria (B), rectal (C), and tubal/adhesion (T) involvement, while EP-D was superior for dyspareunia in T. Chronic pelvic pain (CPP) remained refractory. Higher total #Enzian scores correlated with reduced therapy efficacy.

Limitations

Retrospective design, single-center, small sample, use of aggregated pain scores, and incomplete follow-up may limit generalizability.

Conclusion

Ultrasound-based #Enzian classification correlates with lesion distribution and predicts hormonal therapy efficacy. POP-D therapy is superior at lower #Enzian scores; CPP remains challenging. Findings support individualized medical management and warrant prospective validation including multidimensional pain and quality-of-life assessments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisPelvic PainProgestinsHumansFemaleRetrospective StudiesAdultUltrasonographyPain MeasurementNandroloneTreatment OutcomeNorethindrone Acetate

Stichwörter der Autor:innen

#Enzian classificationEndometriosisHormonal therapyPelvic painTreatment response

Substanzen

ProgestinsNandrolonedienogestNorethindrone Acetate

Autor:innen und Institutionen

  • Mother-Infant Department, University of Modena and Reggio Emilia, Modena, Italy.
  • Mother-Infant Department, University of Modena and Reggio Emilia, Modena, Italy, antonio.lamarca@unimore.it.
  • Unit of Minimally Invasive and Robotic Gynecologic Surgery, University Hospital of Modena, Modena, Italy.

Zitieren

APA

Gambigliani Zoccoli, S., La Marca, A., Di Gianvito, M., Cuoghi Costantini, R., Morini, M., Bertucci, E., & Alboni, C. (2026). The #Enzian Classification as a Predictor of Hormonal Therapy Response in Endometriosis-Associated Pain: A Retrospective Cohort Study in a Referral Center. Gynecologic and Obstetric Investigation, 1-7. https://doi.org/10.1159/000550102

Vancouver

Gambigliani Zoccoli S, La Marca A, Di Gianvito M, Cuoghi Costantini R, Morini M, Bertucci E, et al. The #Enzian Classification as a Predictor of Hormonal Therapy Response in Endometriosis-Associated Pain: A Retrospective Cohort Study in a Referral Center. Gynecologic and Obstetric Investigation. 2026:1-7. doi:10.1159/000550102

BibTeX
@article{GambiglianiZoccoli2026,
  author = {Gambigliani Zoccoli, Sofia and La Marca, Antonio and Di Gianvito, Martina and Cuoghi Costantini, Riccardo and Morini, Matilde and Bertucci, Emma and Alboni, Carlo},
  title = {The #Enzian Classification as a Predictor of Hormonal Therapy Response in Endometriosis-Associated Pain: A Retrospective Cohort Study in a Referral Center},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2026},
  pages = {1--7},
  doi = {10.1159/000550102}
}
Kostenlos starten →